CLS B logo

Clinical Laserthermia Systems AB (publ) Stock Price

OM:CLS B Community·SEK 136.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CLS B Share Price Performance

SEK 4.37
1.53 (53.87%)
SEK 4.37
1.53 (53.87%)
Price SEK 4.37

CLS B Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

6 Risks
2 Rewards

Clinical Laserthermia Systems AB (publ) Key Details

SEK 17.5m

Revenue

SEK 6.6m

Cost of Revenue

SEK 10.9m

Gross Profit

SEK 52.5m

Other Expenses

-SEK 41.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 12, 2026
-1.34
62.44%
-237.96%
0%
View Full Analysis

About CLS B

Founded
2006
Employees
13
CEO
Dan Mogren
WebsiteView website
www.clinicallaser.se

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Recent CLS B News & Updates

Recent updates

No updates